Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/21/2007


1.		Phase II/III Comparison of Radiotherapy with vs without the Hypoxic Cell Sensitizer SR-2508 in Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				18 and over				NCI				RTOG-8527 RTOG-85-27

Last Modified: 11/1/1993


2.		Phase III Randomized Study of IORT with vs without Radiosensitization with SR-2508 in Conjunction with Surgery, External-Beam Radiotherapy, and 5-FU/CF for Patients with Nonmetastatic Recurrent Colorectal Carcinoma (Summary Last Modified 11/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				RTOG-9303 RTOG-93-03

Last Modified: 5/1/1991


3.		Phase II Study of the Radiosensitizer SR 2508 with Radiotherapy in Patients with Locally Extensive Prostate Adenocarcinoma (Summary Last Modified 05/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				DFCI-87022 NCI-T87-0077O, T87-0077

Last Modified: 10/1/1991


4.		Phase II Pilot Study of External Irradiation with Etanidazole Radiosensitization in Patients with Locally Advanced Bladder Cancer (Summary Last Modified 10/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 75								EORTC-22871

Last Modified: 11/8/2007


5.		Phase II Study of External Beam Radiotherapy with Etanidazole in Patients with Locally Advanced Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				RTOG-9020 RTOG-90-20

Last Modified: 3/19/2008


6.		Phase IB Study of Radiosurgery plus SR-2508 for Recurrent Primary Brain Tumors or CNS Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				RTOG-9502 RTOG-95-02

Last Modified: 12/18/2007


7.		Phase I Trial of the Hypoxic Cell Radiosensitizer SR-2508

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				RTOG-8303 NCI-83-C-56

Last Modified: 12/18/2007


8.		Phase I Radiosensitization with Continuous Infusion SR-2508 in Patients Undergoing Interstitial or Intracavitary Radiotherapy for Control of Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				RTOG-8605 DFCI-86020, RTOG-86-05

Last Modified: 4/1/1988


9.		Phase I Chemosensitization with SR-2508 plus Chemotherapy with CTX in Patients with Solid Tumors (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				FCCC-86820 NCI-T86-0235D, T86-0235

Last Modified: 9/1/1989


10.		Phase I Assessment of Clinical, Biological, and Pharmacologic Effects of Intravenous SR-2508 and CTX in Patients with Advanced Malignancies (Summary Last Modified 09/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				WCCC-CO-8793 NCI-T87-0070C, T87-0070

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute